ABL Bio has newly appeared among the top searched stocks.


As of 12:30 PM on the 15th, ABL Bio is trading at 35,700 KRW, up 4.85% from the previous day. This marks a 20.61% increase compared to August 21. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have a net purchase of 44,000 shares of ABL Bio, while institutions have a net sale of 107,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 435,761 shares, while foreigners and institutions have net sold 320,506 shares and 93,035 shares, respectively.


On September 14, ABL Bio was an issue in the market with the headline, 'Stock price slightly rises in early trading... What is the reason?'




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing